MIRLET7I: A Protein Target for Cancer and Neurodegenerative Diseases

Target Name: MIRLET7I

NCBI ID: G406891

MIRLET7I

MIRLET7I: A Protein Target for Cancer and Neurodegenerative Diseases

MIRLET7I (LET7I) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and blood vessels. It is a key regulator of cell growth and differentiation, and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Recent studies have identified MIRLET7I as a potential drug target (or biomarker) for a variety of therapeutic applications. One of the main reasons for its potential as a drug target is its involvement in various signaling pathways that are involved in disease development. For example, MIRLET7I has been shown to be involved in the regulation of cell proliferation, migration, and survival, which are all key factors in the development of cancer.

In addition, MIRLET7I has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This is important for diseases such as heart failure, where the failure of the heart to pump blood properly can lead to decreased blood flow and worsening symptoms.

Another potential mechanism by which MIRLET7I may be involved in disease is its role in modulating the immune response. MIRLET7I has been shown to interact with immune cells and influence the production of antibodies, which are important components of the immune response. This suggests that MIRLET7I may play a role in modulating the immune response to diseases such as cancer and autoimmune disorders.

Despite the potential benefits of MIRLET7I as a drug target, there are also several concerns about its safety and potential side effects. For example, because MIRLET7I is expressed in many different tissues throughout the body, it is difficult to predict exactly how it will interact with other proteins in the body. This could lead to unexpected side effects if MIRLET7I is used in treatments.

Another concern is the potential for MIRLET7I to be misused as an illegal drug. Because MIRLET7I is a naturally occurring protein, it is difficult to obtain through traditional means, such as synthesis or isolation. However, it is possible that someone could attempt to synthesize MIRLET7I in a lab and use it as an illegal drug.

Despite these concerns, recent studies have shown that MIRLET7I is a promising drug target for a variety of diseases. Future research is needed to fully understand its potential and develop safe and effective treatments.

Protein Name: MicroRNA Let-7i

The "MIRLET7I Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIRLET7I comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets